+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biomarkers Market Research Reports

From
From
Biomarkers - Global Strategic Business Report - Product Thumbnail Image

Biomarkers - Global Strategic Business Report

  • Report
  • November 2024
  • 413 Pages
  • Global
From
Biomarkers Global Market Report 2024 - Product Thumbnail Image

Biomarkers Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
From
Biomarker Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Biomarker Collaboration and Licensing Deals 2016-2024

  • Report
  • May 2024
  • 300 Pages
  • Global
From
From
Loading Indicator

The Biomarkers market is a sector of the healthcare industry that focuses on the development and use of biomarkers for the diagnosis, prognosis, and treatment of diseases. Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, or to monitor the progression of a disease. They can also be used to predict the response to a particular treatment. Biomarkers are typically proteins, nucleic acids, or metabolites that are found in the body and can be measured in a variety of ways. Biomarkers are used in a variety of medical applications, including cancer diagnosis and treatment, cardiovascular disease, and neurological disorders. They are also used in drug development, to identify potential drug targets and to monitor the safety and efficacy of drugs. Some of the major companies in the Biomarkers market include Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Sanofi. Show Less Read more